Radioligand discovery and development through bio-mathematical modelling

Radioligand discovery and development through bio-mathematical modelling

Bibliographic Details
Main Authors:	Guo, Q, Brady, M, Salinas, C, Gunn, R
Format:	Conference item
Published:	2009

Similar Items

Towards a biomathematical screening tool for radioligand discovery and development
by: Guo, Q, et al.
Published: (2008)

A biomathematical modeling approach to central nervous system radioligand discovery and development.
by: Guo, Q, et al.
Published: (2009)

Predicting the in vivo performance of TSPO PET radioligands using a biomathematical modelling approach
by: Guo, Q, et al.
Published: (2010)

Discovery and development of brain-penetrant 18F-labeled radioligands for neuroimaging of the sigma-2 receptors
by: Ying Zhang, et al.
Published: (2022-03-01)

Editorial: Response assessment of radioligand therapies
by: Egesta Lopci, et al.
Published: (2022-07-01)

Commercial and business aspects of alpha radioligand therapeutics
by: Emanuele Ostuni, et al.
Published: (2023-02-01)

Multiple laminin receptors: a radioligand binding approach
by: M. V. Marquezini, et al.
Published: (1991-01-01)

Pharmacological Optimization of PSMA-Based Radioligand Therapy
by: Suzanne van der Gaag, et al.
Published: (2022-11-01)

Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists
by: Berthold A. Nock, et al.
Published: (2023-04-01)

Radioligands Targeting Fibroblast Activation Protein (FAP)
by: Thomas Lindner, et al.
Published: (2021-11-01)

PSMA-Directed Radioligand Therapy for Metastatic Prostate Cancer
by: Ellen Heitlinger
Published: (2023-12-01)

Blocking of efflux transporters in rats improves translational validation of brain radioligands
by: Vladimir Shalgunov, et al.
Published: (2020-10-01)

Application of Cleavable Linkers to Improve Therapeutic Index of Radioligand Therapies
by: Joseph Lau, et al.
Published: (2022-08-01)

Design, Synthesis, and Evaluation of Linker-Optimised PSMA-Targeting Radioligands
by: Fanny Lundmark, et al.
Published: (2022-05-01)

Fluorine-18 Labelled Radioligands for PET Imaging of Cyclooxygenase-2
by: Jatinder Kaur, et al.
Published: (2022-06-01)

Evaluation of thiadiazine-based PET radioligands for imaging the AMPA receptor
by: Jiahui Chen, et al.
Published: (2023-12-01)

Monitoring and Surveillance of Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing Radioligand Therapy
by: Thorvardur R. Halfdanarson, et al.
Published: (2023-10-01)

A novel antioxidant ergothioneine PET radioligand for in vivo imaging applications
by: William J. Behof, et al.
Published: (2021-09-01)

Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging
by: Ralf Schirrmacher, et al.
Published: (2019-01-01)

Radioligand therapy (RLT) used to treat cardiac metastasis of pancreatic neuroendocrine tumor
by: Kieran J. Ved, et al.
Published: (2024-03-01)

Albumin-Binding PSMA Radioligands: Impact of Minimal Structural Changes on the Tissue Distribution Profile
by: Luisa M. Deberle, et al.
Published: (2020-05-01)

A comparative study of two PET radioligands for the imaging of neuroinflammation in an animal model of multiple sclerosis
by: Dickens, A, et al.
Published: (2012)

PSMA Theranostics: Review of the Current Status of PSMA-Targeted Imaging and Radioligand Therapy
by: Wallace Jones, et al.
Published: (2020-05-01)

Key-Protease Inhibition Regimens Promote Tumor Targeting of Neurotensin Radioligands
by: Panagiotis Kanellopoulos, et al.
Published: (2020-06-01)

Visualizing GABA transporters in vivo: an overview of reported radioligands and future directions
by: Niels Knippenberg, et al.
Published: (2023-05-01)

Radiosynthesis and in Vivo Evaluation of Two PET Radioligands for Imaging α-Synuclein
by: Xiang Zhang, et al.
Published: (2014-03-01)

Molecular imaging phenotyping for selecting and monitoring radioligand therapy of neuroendocrine neoplasms
by: Amir Iravani, et al.
Published: (2022-06-01)

PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects
by: Erica M. Richards, et al.
Published: (2018-07-01)

Blocking Studies to Evaluate Receptor-Specific Radioligand Binding in the CAM Model by PET and MR Imaging
by: Jessica Löffler, et al.
Published: (2022-08-01)

Derisking the Cu-mediated (18)F-fluorination of heterocyclic positron emission tomography radioligands
by: Taylor, N, et al.
Published: (2017)

Novel Radioligands for Cyclic Nucleotide Phosphodiesterase Imaging with Positron Emission Tomography: An Update on Developments Since 2012
by: Susann Schröder, et al.
Published: (2016-05-01)

The Traumatic Inoculation Process Affects TSPO Radioligand Uptake in Experimental Orthotopic Glioblastoma
by: Lukas Gold, et al.
Published: (2024-01-01)

Development of a novel radioligand for imaging 18-kD translocator protein (TSPO) in a rat model of Parkinson’s disease
by: Chun-Yi Wu, et al.
Published: (2019-09-01)

EXPLORING THE CREATIVE MATHEMATICAL REASONING OF MATHEMATICS EDUCATION STUDENT THROUGH DISCOVERY LEARNING
by: Titin Masfingatin, et al.
Published: (2020-06-01)

Mathematical modeling and simulation of electromagnetohydrodynamic bio-nanomaterial flow through physiological vessels
by: Katta Ramesh, et al.
Published: (2022-08-01)

The Effects of Radioligand Therapy on Quality of Life and Sexual Function in Patients with Neuroendocrine Neoplasms
by: Pasqualino Malandrino, et al.
Published: (2022-12-01)

Targeting mTORC1 Activity to Improve Efficacy of Radioligand Therapy in Cancer
by: Michal Grzmil, et al.
Published: (2022-12-01)

A radioligand binding assay for the insulin-like growth factor 2 receptor.
by: Pavlo Potalitsyn, et al.
Published: (2020-01-01)

An in vivo Pig Model for Testing Novel Positron Emission Tomography Radioligands Targeting Cerebral Protein Aggregates
by: Nakul Ravi Raval, et al.
Published: (2022-03-01)

Editorial: Development of selective carbon-11 radioligands for target-based PET molecular imaging in oncology, cardiology and neurology
by: Sridhar Goud Nerella, et al.
Published: (2023-01-01)